| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $240.2M | -34.4% |
| Cost of Revenue | $191.0M | -19.7% |
| Gross Profit | $49.2M | -61.7% |
| R&D Expense | $19.1M | +9.3% |
| SG&A Expense | $32.6M | +3.1% |
| Operating Income | -$51.5M | -352.0% |
| Interest Expense | $1.2M | +218.5% |
| Pre-tax Income | -$54.5M | -370.3% |
| Income Tax | $5.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.4M | -69.8% |
| Accounts Receivable | $43.3M | +20.5% |
| Inventory | $71.3M | -30.1% |
| Current Assets | $135.2M | -30.0% |
| Total Assets | $163.4M | -29.1% |
| Current Liabilities | $64.3M | -17.7% |
| Total Liabilities | $74.4M | -16.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.8M | — |
| Capital Expenditures | $3.5M | -36.9% |
| Investing Cash Flow | -$3.5M | +56.3% |
| Financing Cash Flow | $19.7M | — |
| Free Cash Flow | -$45.4M | -663.2% |
| +109.8% |
| Net Income | -$59.5M | -436.0% |
| EPS (Basic) | -$3.62 | -426.1% |
| EPS (Diluted) | -$3.62 | -473.2% |
| Stockholders' Equity |
| $88.9M |
| -37.1% |